BRIANA HUISKEN: Open Payments
NPI 1366180044 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,439 in 40 payments from 8 companies in 2025. Trend: 2023 $784 · 2024 $1,166 · 2025 $1,439
Food & beverage: $1,089Honoraria: $350
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 8 | $436 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $336 |
| Novo Nordisk Inc | 15 | $246 |
| Sequel Med Tech, LLC | 3 | $181 |
| Medtronic, Inc. | 1 | $122 |
| Tandem Diabetes Care, Inc. | 1 | $84 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
Products named: GVOKE HYPOPEN, JARDIANCE, TWIIST, Ozempic, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, Wegovy, Yorvipath.
Industry payments across MI — which companies pay providers there.
